25 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Fearon, Interventional Cardiologist in Stanford, CA?
Dr. William Fearon, MD is an Interventional Cardiologist, who primarily practices in Stanford, CA. He has been practicing for over 25 years and is board certified by the American Board of Internal Medicine. Dr. Fearon graduated from Columbia Univ College of Physicians And Surgeons and completed his residency at Stanford Univ Hosp, Cardiovascular Diseases; Stanford Univ Hosp, Internal Medicine. Dr. Fearon is fluent in English, and is currently seeing new patients. Dr. Fearon’s practice accepts Cigna, Kaiser Permanente, Medicaid, Medicare, UnitedHealthcare, Aetna and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Fearon’s office at (650) 723-4000.
What are Areas of Expertise for Dr. Fearon?
Dr. William Fearon, MD is a highly-rated, board-certified Interventional Cardiologist known for expertly diagnosing, treating, and managing a wide array of related conditions or procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Fearon empowers patients to confidently navigate their health journey, specializing in Aortic Valve Replacement, Coronary Artery Disease, Percutaneous Coronary Intervention, or comprehensive wellness support. Serving the Stanford/CA community, Dr. Fearon is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Fearon go to medical school and complete their residency?
Fellowship: Stanford University School of Medicine CA | Stanford University School of Medicine CA
Residency: Stanford Univ Hosp, Cardiovascular Diseases; Stanford Univ Hosp, Internal Medicine | Stanford University Medical Center
Medical School: Columbia Univ Coll of Physicians And Surgeons, New York Ny | Columbia Univ College of Physicians And Surgeons
Is Dr. Fearon board certified in Interventional Cardiologist?
Yes, Dr. William Fearon, MD is board certified by the American Board of Internal Medicine , American Board of Internal Medicine since 2001, American Board of Internal Medicine since 2002
What languages does Dr. Fearon speak?
Dr. Fearon and their clinical team can communicate with patients in the following languages:
English
What conditions does Dr. Fearon treat?
As a Interventional Cardiologist, Dr. Fearon diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Fearon. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.
Also known as:
- Hardening of the Arteries in the Heart without Chest Pain
- Coronary Artery Disease with Angina
- Unstable Angina
- Atherosclerosis
- Coronary Artery Disease
- Silent Coronary Artery Disease
- Asymptomatic Atherosclerosis
- Atherosclerotic Heart Disease with Angina
- Chest Pain from Heart Disease
- Angina Pectoris
- Unstable Chest Pain
- Acute Coronary Syndrome
- Atherosclerotic Heart Disease with Unstable Angina
ICD-10 Codes:
- I2510: Atherosclerotic heart disease of native coronary artery without angina pectoris
- I25118: Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris
- I25119: Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris
- I25110: Atherosclerotic heart disease of native coronary artery with unstable angina pectoris
Also known as:
- Aortic Valve Disorder
- Narrowed Aortic Valve
- Rheumatic Mitral Valve Disease
- Heart Valve Disease
- Streptococcal Infection
- Aortic Valve Disease
- Aortic Valve Problem
- Aortic Valve Stenosis
- Tight Aortic Valve
- Rheumatic Mitral Valvulopathy
- Mitral Valve Problems from Rheumatic Fever
- Rheumatic Heart Valve Disorder
ICD-10 Codes:
- I359: Nonrheumatic aortic valve disorder, unspecified
- I350: Nonrheumatic aortic (valve) stenosis
- I059: Rheumatic mitral valve disease, unspecified
Also known as:
- Having a Prosthetic Heart Valve
- Heart Valve Disease
- Artificial heart valve
- Mechanical heart valve
- Bioprosthetic valve
ICD-10 Codes:
- Z952: Presence of prosthetic heart valve
Also known as:
- Pre-Procedure Heart Examination
- Pre-Surgery Cardiac Checkup
- Heart Health Assessment (Before Procedure)
- Cardiovascular Clearance Exam
ICD-10 Codes:
- Z01810: Encounter for preprocedural cardiovascular examination
Also known as:
- High Cholesterol
- Cholesterol
- Triglycerides
- Hyperlipidemia
- High lipids
- Dyslipidemia
ICD-10 Codes:
- E785: Hyperlipidemia, unspecified
Also known as:
- Heart Transplant Aftercare
- Heart Transplantation
- Post-heart transplant care
- Heart transplant follow-up
- Cardiac transplant recovery
ICD-10 Codes:
- Z4821: Encounter for aftercare following heart transplant
Also known as:
- Other Pre-Procedure Examination
- Various pre-op checks
- Miscellaneous pre-surgery exams
- Other pre-treatment assessments
ICD-10 Codes:
- Z01818: Encounter for other preprocedural examination
Also known as:
- Shortness of Breath
- Breathing Problems
- Difficulty breathing
- Breathlessness
- Dyspnea
ICD-10 Codes:
- R0600: Dyspnea, unspecified
- R0602: Shortness of breath
Also known as:
- Heart Palpitations
- Atrial Fibrillation
- Arrhythmia
- Skipped Heartbeat
- Fluttering Heart
- Pounding Heart
- Afib
- A-fib
- Irregular heart rhythm
ICD-10 Codes:
- R002: Palpitations
- I4891: Unspecified atrial fibrillation
Also known as:
- Unspecified Illness
- General sickness
- Undiagnosed illness
- Feeling unwell
ICD-10 Codes:
- R69: Illness, unspecified
Also known as:
- Chest Pain
- Chest discomfort
- Thoracic pain
- Upper body pain
ICD-10 Codes:
- R079: Chest pain, unspecified
Also known as:
- High Blood Pressure
- Hypertension
- Primary Hypertension
- Essential Hypertension
ICD-10 Codes:
- I10: Essential (primary) hypertension
Also known as:
- Heart Disease
- Heart Condition
- Cardiac Disease
- Heart Problem
ICD-10 Codes:
- I519: Heart disease, unspecified
Which procedures does Dr. Fearon perform as a Interventional Cardiologist?
As a Interventional Cardiologist, procedures performed by an Dr. William Fearon may include:
- Balloon Angioplasty / Stent
- Cardiac Catheterization
- Carotid Endarterectomy
- Heart Valve Repair / Valvuloplasty
- Pacemaker Implant
For detailed information, please contact Dr. Fearon's office.
Does Dr. Fearon accept my insurance?
Dr. Fearon accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Fearon accept in Stanford, CA?
Dr. Fearon in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Advantage
All Other Third Party
Blue Shield of California
Central California Alliance for Health
CVS Health (formerly Aetna)
Express Scripts
Medicare
Other Provider Networks
Santa Clara Family Health Plan
UnitedHealthcare
View All Insurances
Where is Dr. Fearon's office located?
Recognitions
Publications
Prognostic Value of the Index of Microcirculatory Resistance Me
Circulation
Fractiol Flow Reserve-Guided PCI versus Medical Therapy in Stable Corory Disease
NEW ENGLAND JOURL OF MEDICINE, 2012
Functiol SYNTAX Score for Risk Assessment in Multivessel Corory Artery Disease
JOURL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011
Economic Evaluation of Fractiol Flow Reserve
CIRCULATION, 2010
Fractiol Flow Reserve versus Angiography for Guiding Percutaneous Corory Intervention
NEW ENGLAND JOURL OF MEDICINE, 2009
Predictive value of the index of microcirculatory resistance in patients with ST
JOURL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008
Ratiole and design of the fractiol flow reserve versus angiography for multivessel evaluation
AMERICAN HEART JOURL, 2007
Invasive assessment of the corory microcirculation - Superior reproducibility
CIRCULATION, 2006
Microvascular resistance is not influenced by epicardial corory artery stenosis severity
CIRCULATION, 2004
Novel index for invasively assessing the corory microcirculation
CIRCULATION, 2003
Corory Microvascular Dysfunction After ST-Segment-Elevation Myocardial Infarction
Circulation. Cardiovascular interventions, 2013
Fractiol flow reserve assessment of left main stenosis
Circulation. Cardiovascular interventions, 2013
ST-Elevation Myocardial Infarction Following Heart Transplantation as an Unusual Presentation of
TRANSPLANTATION PROCEEDINGS, 2013
Physiologic approach for corory intervention.
The Korean jourl of interl medicine, 2013
Variability in quantitative and qualitative alysis of intravascular ultrasound
Catheterization and cardiovascular interventions : official jourl of t
Calculation of the Index of Microcirculatory Resistance Without Corory Wedge Pressure Me
JACC-CARDIOVASCULAR INTERVENTIONS, 2013
Clinical and Functiol Correlates of Early Microvascular Dysfunction After Heart Transplantation
CIRCULATION-HEART FAILURE, 2012
The Impact of Downstream Corory Stenoses on Fractiol Flow Reserve Assessment of Intermediate Left
JACC-CARDIOVASCULAR INTERVENTIONS, 2012
The Impact of Sex Differences on Fractiol Flow Reserve
JACC-CARDIOVASCULAR INTERVENTIONS, 2012
The Index of Microcirculatory Resistance Predicts Myocardial Infarction Related to Percutaneous
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2012
Most accurate definition of a high femoral artery puncture
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012
PROGNOSTIC VALUE OF THE INDEX OF MICROCIRCULATORY RESISTANCE AFTER PRIMARY PERCUTANEOUS CORORY
Yong, A., Loh, J., McGeoch, R., Shah, M., Ho, M., Daniels, D., Berry, , 2012
Corory Microcirculatory Resistance Is Independent of Epicardial Stenosis
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2012
Comparison of the Frequency of Corory Artery Disease in Alcohol-Related Versus Non
AMERICAN JOURL OF CARDIOLOGY, 2011
Is a Myocardial Infarction More Likely to Result From a Mild Corory Lesion or an Ischemia
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2011
Comparison of Drug-Eluting Versus Bare Metal Stents in Cardiac Allograft Vasculopathy
AMERICAN JOURL OF CARDIOLOGY, 2011
Impact of Donor-Transmitted Atherosclerosis on Early Cardiac Allograft Vasculopathy
TRANSPLANTATION, 2011
The Index of Microcirculatory Resistance (IMR) in Takotsubo Cardiomyopathy
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2011
CCR2 Antagonist Inhibits Neointimal Proliferation Post CororyStent Deployment
Teramoto, T., Ikeno, F., katani, D., Otake, H., Lyons, J. K., Sullivan
Long-Term Outcomes After Percutaneous Corory Intervention of Left Main Corory Artery for Treatment
AMERICAN JOURL OF CARDIOLOGY, 2010
3 ',4-Dihydroxyflavonol reduces infarct size in a porcine acute myocardial ischaemia-reperfusion
Teramoto, T., Ikeno, F., Lyons, J., Thomas, C. J., May, C. N., Woodman, 2010
CCR2 antagonist inhibits neointimal proliferation post corory stent deployment
Teramoto, T., Ikeno, F., katani, D., Otake, H., Lyons, J. K., Sullivan, 2010
Outcomes of Percutaneous Corory Intervention
JACC-CARDIOVASCULAR INTERVENTIONS, 2010
Fractiol Flow Reserve Versus Angiography for Guiding Percutaneous Corory Intervention
JOURL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010
Balloon aortic valvuloplasty: modern indications and techniques for a niche therapy.
Expert review of cardiovascular therapy, 2010
Angiographic Versus Functiol Severity of Corory Artery Stenoses
JOURL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010
Intriguing Pen-Strut Low
CIRCULATION JOURL, 2010
Quantitative assessment of corory microvascular function in patients with
EUROINTERVENTION, 2010
Atomic and Functiol Evaluation of Bifurcation Lesions Undergoing Percutaneous Corory Intervention
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2010
Use of a Low-Profile, Compliant Balloon for Percutaneous Aortic Valvuloplasty
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2010
Fractiol Flow Reserve
JACC-CARDIOVASCULAR INTERVENTIONS, 2010
Impact of Drug-Eluting Stent Length on Outcomes Less Is More ... More or Less
JACC-CARDIOVASCULAR INTERVENTIONS, 2010
3 ', 4-Dihydroxyflavonol Reduces Infarct Size in a Porcine Acute Myocardial Infarction-Reperfusion
Tomohiko, T., Ikeno, F., Lyons, J. K., Jarrott, B., Woodman, O. L., Ma, 2009
Safety and Efficacy of Drug Eluting Stents for Treatment of Cardiac Allograft Vasculopathy
Ng, M. K., Tremmel, J., Ikeno, F., Lee, D. P., Yeung, A. C., Fearon, W, 2009
Expanding role of fractiol flow reserve in the cardiac catheterization laboratory.
Expert review of cardiovascular therapy, 2009
Baseline Fractiol Flow Reserve
JACC-CARDIOVASCULAR INTERVENTIONS, 2009
Microvascular Dysfunction
Khazanie, P., Haddad, F., Simos, A. M., Pham, M., Weisshaar, D. M., De, 2009
Microvascular Drysfunction
Khazanie, P., Haddad, F., Simos, A. M., Weissbaar, D. M., Desai, S. V., 2009
Safety and Performance of Targeted Rel Therapy: The Be-RITe! Registry
JOURL OF ENDOVASCULAR THERAPY, 2009
Inflammation and cardiovascular disease - Role of the interleukin-1 receptor antagonist
CIRCULATION, 2008
Effect of rapamycin therapy on corory artery physiology early after cardiac transplantation
AMERICAN HEART JOURL, 2008
In Vivo Comparison Between Optical Coherence Tomography
JACC-CARDIOVASCULAR INTERVENTIONS, 2008
Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: Modulation by sirolimus
TRANSPLANTATION, 2008
The pathophysiology and clinical course of the normal corory angi syndrome (cardiac syndrome x)
PROGRESS IN CARDIOVASCULAR DISEASES, 2008
Determints of lumen loss between years 1 and 2 after cardiac transplantation
TRANSPLANTATION, 2007
Optical coherence tomography compared to intravascular ultrasound
Ikeno, F., Suzuki, Y., Koizumi, T., Yeung, A. C., Fitzgerald, P. J., F, 2007
Changes in corory atomy and physiology after heart transplantation
AMERICAN JOURL OF CARDIOLOGY, 2007
Prognostic significance of PVCs and resting heart rate
ANLS OF NONINVASIVE ELECTROCARDIOLOGY, 2007
Interplay between systemic inflammation
JOURL OF HEART AND LUNG TRANSPLANTATION, 2007
Changes in corory arterial dimensions early after cardiac transplantation
TRANSPLANTATION, 2007
Aggressive prophylaxis against cytomegalovirus plays a key role
Sakurai, R., Yamasaki, M., Pote, L., Hirohata, A., Honda, Y., Yock, P., 2007
Physiologic assessment of rel artery stenosis - Will history repeat itself? Editorial comment
JOURL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006
Impact of donor-transmitted atherosclerosis on early cardiac allograft vasculopathy
Yamasaki, M., Sakurai, R., Hirohata, A., Honda, Y., Yock, P. G., Fitzg, 2006
Index of microcirculatory resistance
Shah, M., Tremmel, J., Brinton, T., Wilson, A., Schnittger, I., Lee, D, 2006
Optical coherence tomography: In-vivo correlation withhistology
Ikeno, F., Koizumi, T., Yeung, A. C., Yock, P. G., Fitzgerald, P. J., , 2006
T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease
CIRCULATION, 2006
Physiological assessment of corory artery disease in the cardiac catheterization laboratory
CIRCULATION, 2006
Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical
TRANSPLANTATION, 2006
Discordant changes in epicardial and microvascular corory physiology after cardiac transplantation
JOURL OF HEART AND LUNG TRANSPLANTATION, 2006
Rapamycin therapy improves corory physiology after cardiac transplantation
Sinha, S. S., Lee, D. P., Pham, M. X., Vagelos, R. H., Hunt, S. A., Va, 2006
Index of microcirculatory resistance
Shah, M. G., Tremmel, J., Brinton, T., Wilson, A., Schnittger, I., Lee, 2006
Prevention of subclinical CMV infection reduces cardiac allograft dise
Pote, L., Fearon, W., Holweg, C., Luikart, H., Chin, C., Cooke, J., Le, 2006
Selective rel arterial infusion of fenoldopam for the prevention of contrast-induced nephropathy.
Jourl of interventiol cardiology, 2006
Inhibition of cardiac allograft vasculopathy by sirolimus and mycofenolate
Pote, L., Fearon, W., Sydow, K., Holweg, C., Luikart, H., Mocarski, E., 2006
Changes in the atomy and physiology of the corory circulation after cardiac transplantation
Hirohata, A., kamura, M., Waseda, K., Valantine, H. A., Hunt, S. A., H, 2005
Invasive assessment of the corory microcirculation
Ng, M. K., Yeung, A. C., Fearon, W. F., 2005
Design and ratiole for the targeted intra-rel fenoldopam for avoidance of nephropathy
Price, M. J., Garcia, L., Davidson, C., McNeil, J., Cohen, M. G., Math, 2005
Impact of direct corory stenting on neointimal distribution within sirolimus-eluting stents
Hirohata, A., Ako, J., Sakurai, R., Fearon, W. F., Caputo, R., Mishkel, 2005
Risk factors for the development of retroperitoneal hematoma after percutaneous
JOURL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005
Corory endothelial dysfunction in cardiac transplant recipients is related to elevated levels of
Fearon, W. F., Wang, B. Y., Hirohata, A., kamura, M., Pote, L., Valent, 2005
Pioglitazone-induced heart failure despite normal left ventricular function
AMERICAN JOURL OF MEDICINE, 2004
Tako-tsubo-like left ventricular dysfunction
American jourl of geriatric cardiology, 2004
Systemic inflammation links impaired glucose metabolism to cardiac allograft v
Pote, L., Biadi, O., Fearon, W. B., Holweg, C. T., Luikart, H. I., Moc, 2004
Corory endothelial dysfunction in cardiac transplant recipients is related to elevated levels of
Fearon, W. F., Wang, B. Y., kamura, M., Pote, L., Valantine, H. A., Ye, 2004
Epicardial stenosis severity does not affect minimal microcirculatory resistance
CIRCULATION, 2004
The current and future role of percutaneous corory intervention in patients with corory artery
Jourl of interventiol cardiology, 2004
Minimal microvascular resistance is not influenced by epicardial stenosis severity
Fearon, W. F., Aarnoudse, W., De Bruyne, B., Cooke, D. T., Balsam, L. , 2004
Cytomegalovirus infectious burden is proportiol to cardiac allograft vasculopathy
Pote, L., Magelli, C., Ortolani, P., Fearon, W. F., Grigioni, F., Magn, 2004
Women remain at higher risk for retroperitoneal hematoma after percutaneous corory intervention
Farouque, H. M., Tremmel, J. A., Aggarwal, M., Shabari, F. R., Fearon,, 2004
Exaggeration of neointimal hyperplasia following stent deployment in type B bifurcation lesions
Hirohata, A., kamura, M., Fearon, W. F., Honda, Y., Yock, P. G., Fitzg, 2004
Evaluation of high-pressure retrograde corory venous delivery of FGF-2 protein
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2004
Comparison of corory thermodilution and Doppler velocity for assessing corory flow reserve
CIRCULATION, 2003
Endothelial nitric oxide synthesis is severely impaired after cardiac transplantation: Role of ADMA
Fearon, W. F., Wang, B. Y., Valantine, H. A., Mocarsky, E. S., Yeung, , 2003
Simultaneous assessment of fractiol
CIRCULATION, 2003
Cost-effectiveness of measuring fractiol flow reserve to guide corory interventions
AMERICAN HEART JOURL, 2003
Adjunctive platelet glycoprotein IIb
CIRCULATION, 2003
Is corory thermodilution as accurate as Doppler velocity for measuring corory flow reserve?
Fearon, W. F., Balsam, L. B., Farouque, H. M., Caffarelli, A. D., Robb, 2003
Physiologic interrogation of transplant arterioparthy: Fil results
Fearon, W. F., kamura, M., Lee, D. P., Rezaee, M., Vagelos, R. H., Hun, 2003
A novel invasive assessment of the corory microcirculation
Fearon, W. F., Balsam, L. B., Farouque, H. M., Caffarelli, A. D., Robb, 2003
Evaluating intermediate corory lesions in the cardiac catheterization laboratory.
Reviews in cardiovascular medicine, 2003
Physiologic interrogation of transplant arteriopathy
Fearon, W. F., kamura, M., Lee, D. P., Rezaee, M., Vagelos, R. H., Hun, 2002
Myocardial delivery of labeled fibroblast growth factor-2 protein by high pressure
Fearon, W. F., Ikeno, F., Price, E., Bailey, L. R., Herity, N. A., Fit, 2002
Corory pressure measurement after stenting predicts adverse events at follow-up
CIRCULATION, 2002
High pressure, retrograde
Fearon, W. F., Rezaee, M., Hiatt, B. L., Ikeno, F., Bailey, L., Suzuki, 2002
A comparison of treadmill scores to diagnose corory artery disease
CLINICAL CARDIOLOGY, 2002
A comparison of angiographic and physiologic correlates to myocardial perfusion
Fearon, W., Hiatt, B., Rezaee, M., Herity, N., Suzuki, T., Ikeno, F., , 2001
Fractiol flow reserve compared with intravascular ultrasound guidance
CIRCULATION, 2001
Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men
AMERICAN HEART JOURL, 2001
Clinical utility of the exercise ECG in patients with diabetes and chest pain
CHEST, 2001
Images in cardiology. Giant left ventricular pseudoaneurysm.
Clinical cardiology, 2001
Safety and efficacy of high pressure retrograde cardiac venous injection. Implications for regiol
Herity, N. A., Fearon, W., Hiatt, B. L., Rezaee, M., Suzuki, T., Lee, , 2001
Fractiol flow reserve compared to intravascular ultrasound guidance for optimal stent deployment
Fearon, W. F., Takagi, A., Lu, J., Jeremias, A., Samady, H., Powers, E, 2001
Is the use of fractiol flow reserve to guide corory interventions cost-effective?
Fearon, W. F., Yeung, A. C., Honda, Y., Yock, P. G., Heidenreich, P. A, 2001
Use of fractiol myocardial flow reserve to
AMERICAN JOURL OF CARDIOLOGY
What is Dr. Fearon's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Fearon's National Provider Identifier (NPI) number is 1770671455.
What common questions do patients ask about Dr. Fearon?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Fearon
What is Dr. William Fearon's specialty?
Dr. Fearon is a Interventional Cardiologist near Stanford, CA. A branch of medicine within cardiology that employs advanced imaging and diagnostic techniques to assess blood flow and pressure in the coronary arteries and heart chambers. This specialty also utilizes technical procedures and medications to address abnormalities that affect cardiovascular function. Contact Dr. Fearon to book an appointment today.
Is this Dr. William Fearon affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Fearon is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
Where can I learn more about Interventional Cardiologist?
Explore Interventional Cardiologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is William Fearon accepting new patients in Stanford, CA?
Yes, Dr. William Fearon is accepting new patients at this time.
Does Dr. William Fearon offer online booking?
Please contact Dr. Fearon's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with William Fearon?
Please contact Dr. Fearon's office at (650) 723-4000 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. William Fearon have?
Dr. William Fearon is certified by the American Board of Internal Medicine.
Other Interventional Cardiologist Near Stanford, CA
Interventional Cardiologist
Accepting patientsInterventional Cardiologist
Accepting patients
Interventional Cardiologist
Accepting patients